-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – YPP-10 in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - YPP-10 in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. YPP-10 in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: YP-P10...
-
Company Profile
P10 Holdings Inc – Company Profile
P10 Inc (P10) is a provider of multi-asset class private market solutions. The company offers private solutions including private equity, venture capital, impact investing and private credit services. It also structure, manage and monitor portfolios of private market investments which include specialized funds and customized separate accounts within primary investment funds, secondary investments, direct investments and co-investments. The company offers its services to family offices, wealth managers, financial institutions, endowments and foundations, insurance companies and sovereign wealth funds. It operates...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – YPP-10
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry YPP-10 Drug Details YP-P10 is under development for the treatment of keratoconjunctivitis sicca (dry...
-
Product Insights
Follicular Lymphoma Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, H2, 2017" provides an overview of Follicular Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Follicular Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...